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Edited by Lukas HuberAbstract Our previous study indicated that interleukin (IL)-1b
induces expression of several Wnt proteins in chondrocytes and
causes chondrocyte dediﬀerentiation via the c-Jun/activator pro-
tein-1 (AP-1) pathway. This study examined whether Wnt-3a
causes chondrocyte dediﬀerentiation via the c-Jun/AP-1 path-
way. Wnt-3a inhibited chondrogenesis of mesenchymal cells by
stabilizing cell–cell adhesion in a manner independent of b-cate-
nin transcriptional activity. Wnt-3a also induced dediﬀerentiation
of articular chondrocytes by stimulating the transcriptional
activity of b-catenin-T cell-factor/lymphoid-enhancer-factor
(Tcf/Lef) complex. In chondrocytes, Wnt-3a caused the expres-
sion of c-Jun and its phosphorylation by c-Jun N-terminal kinase
(JNK), resulting in activation of AP-1. AP-1 activation sup-
pressed the expression of Sox-9, a major transcription factor
regulating type II collagen expression. Collectively, our results
suggest that Wnt-3a inhibits chondrogenesis by stabilizing cell–
cell adhesion and that it causes dediﬀerentiation of chondrocytes
by activating of b-catenin-Tcf/Lef transcriptional complex and
the c-Jun/AP-1 pathway.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dediﬀerentiation1. Introduction
Cartilage is developed by the diﬀerentiation of mesenchymal
cells into chondrocytes [1]. Diﬀerentiated chondrocytes in artic-
ular cartilage maintain cartilage homeostasis by synthesizing
cartilage-speciﬁc matrix molecules. However, this homeostasis
is destroyed during the pathogenesis of cartilage diseases such
as arthritis, which involves loss of a diﬀerentiated phenotype
(dediﬀerentiation) and apoptosis of chondrocytes [2].
During the process of diﬀerentiation and in the maintenance
of diﬀerentiated phenotypes, chondrocytes integrate a complex
array of signals from local or systemic factors. Such factors
include the Wnt family of proteins, which have essential func-
tions in cartilage and bone development [1,2]. For instance,Abbreviations: AP-1, activator protein-1; DMEM, Dulbeccos modi-
ﬁed Eagles medium; GAPDH, glyceraldehyde 3-phosphate dehydro-
genase; IL-1b, interleukin-1b; JNK, c-Jun N-terminal kinase; PNA,
peanut agglutinin; RT-PCR, reverse transcription-polymerase chain
reaction; Tcf/Lef, T cell-factor/lymphoid-enhancer-factor
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cartilage and regulate chondrogenesis with distinct mecha-
nisms [1,3]. Among the Wnt family, Wnt-3a and -7a are
involved in the regulation of chondrogenesis and cartilage
development both in vivo and in vitro [4–9]. In the diﬀerenti-
ated articular chondrocytes, interleukin (IL)-1b produced from
chondrocytes, synovial ﬁbroblasts, and inﬂammatory cells is a
major catabolic pro-inﬂammatory cytokine involved in carti-
lage destruction [10–12]. Likewise, Wnt proteins are thought
to be involved in the maintenance and destruction of cartilage.
This possibility is indirectly supported by the observation that
several Wnt proteins, frizzled receptors, and the secreted
frizzled-related protein FrzB-2 are strongly expressed in ar-
thritic cartilage [13,14]. More direct evidence for the involve-
ment Wnt signaling in cartilage destruction includes our
previous observations that chondrocytes express low levels of
b-catenin, that the accumulation of b-catenin is suﬃcient to
cause dediﬀerentiation of chondrocytes [15], and that exposure
of chondrocytes to Wnt-7a causes chondrocyte dediﬀerentia-
tion via stimulation of b-catenin transcriptional activity [16].
Our previous study also indicated that IL-1b causes dediﬀer-
entiation of primary cultured articular chondrocytes via the
c-Jun/activator protein-1 (AP-1) pathway [17]. In addition,
IL-1b induces Wnt expression in chondrocytes, which causes
their dediﬀerentiation by stimulating b-catenin-T cell-factor/
lymphoid-enhancer-factor (Tcf/Lef) transcriptional activity
[16]. In the present study, we therefore examined the role
and regulatory mechanisms of the chondrogenesis of mesen-
chymal cells and the dediﬀerentiation of articular chondrocytes
by Wnt-3a. These eﬀorts were focused on whether the Wnt
protein causes chondrocyte dediﬀerentiation via the c-Jun/
AP-1 pathway.2. Materials and methods
2.1. Cell culture and assay of chondrocyte diﬀerentiation
As described previously [18,19], mesenchymal cells, which were iso-
lated from chicken embryo wing buds, were grown in micromass cul-
ture used to induce chondrogenesis. Chondrifying mesenchymal cells
were treated with Wnt-3a conditioned medium as described for each
experiment. Chondrogenesis was determined by examining the expres-
sion of type II collagen with Western blot analysis and the accumula-
tion of sulfated glycosaminoglycan with Alcian blue staining. Articular
chondrocytes from cartilage slices of 2-week-old New Zealand white
rabbits were isolated with 0.2% collagenase type II as reported previ-
ously [20]. The cells were treated with Wnt-3a conditioned medium
as described for each experiment. Dediﬀerentiation of chondrocytes
was determined by examining the suppression of type II collagen
and the onset of type I collagen expression by reverse transcription-
polymerase chain reaction (RT-PCR).blished by Elsevier B.V. All rights reserved.
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Control or Wnt-3a conditioned medium was prepared as described
previously [16]. Brieﬂy, stable mouse ﬁbroblast L929 cell lines were
generated by transfection of L929 cells with Wnt-3a cDNA or empty
vector (control). Expression of Wnt-3a was conﬁrmed by RT-PCR.
After growing to 90% conﬂuence, control and Wnt-expressing L929
cells were washed and maintained in serum-free Dulbeccos modiﬁed
Eagles medium (DMEM; Gibco-BRL, Gaithersburg, MD) for 36 h.
Conditioned media were clariﬁed by centrifugation at 10000 · g for
5 min, followed by ﬁltration (0.2 lm pore size), and concentrated 20-
fold by ultraﬁltration in Amicon-stirred cells (Millipore, Billerica,
MA) using a YM membrane with a 10-kDa molecular mass cut-oﬀ.
2.3. Immunocytochemistry and immunoﬂuorescence microscopy
Spots of micromass culture were stained with Alcian blue to detect
sulfated glycosaminoglycan and with peanut agglutinin (PNA; Vector
Laboratories, Inc., Burlingame, CA) to detect precartilage condensa-
tion [21]. PNA binding was visualized by developing with Vectastain
ABC and DAB substrate solution kits (Vector Laboratories). Alterna-
tively, spots of micromass culture were ﬁxed in 4% paraformaldehyde
overnight at 4 C, dehydrated with a graded series of ethanol, embed-
ded in paraﬃn, and cut into 4 lm sections. Sections were stained by
standard procedures using mouse monoclonal antibodies against b-
catenin (BD Transduction Laboratories, Lexington, KY) and visual-
ized by developing with a kit from DAKO Co. (Carpinteria, CA)
[15]. Distribution of b-catenin in chondrocytes was determined by
immunoﬂuorescence microscopy as reported previously (15) using a
b-catenin antibody (BD Transduction Laboratories). Brieﬂy, chondro-
cytes were ﬁxed with 3.5% paraformaldehyde in PBS for 10 min at
room temperature. The cells were permeabilized and blocked with
0.1% Triton X-100 and 5% fetal calf serum in PBS for 30 min. The
ﬁxed cells were washed and incubated for 1 hour with antibody
(10 lg/ml) against b-catenin. The cells were washed, incubated with
rhodamine-conjugated secondary antibodies for 30 min, and observed
under a ﬂuorescence microscope.
2.4. RT-PCR
Total RNA was isolated using RNA STAT-60 (Tel-Test B, Inc.,
Friendswood, TX) and reverse-transcribed with MoMLV-RT (Gibco-
BRL) as previously described [16]. The following primers and conditions
were used for PCR in rabbit articular chondrocytes: for type I
collagen (COL1A1; 441-bp product), 5 0-GGC TTT CCT GGA GAG
AAA GG-3 0 (sense) and 5 0-ATA GAA CCA GCA GGG CCA GG-3 0
(antisense) with an annealing temperature of 60 C; for type II collagen
(COL2A1; 370-bpproduct), 5 0-GACCCCATGCAGTACATGCG-3 0
(sense) and 5 0-AGC CGCCAT TGA TGGTCTCC-3 0 (antisense) with
an annealing temperature of 60 C; for c-Jun (250-bp product), 5 0-ATG-
GAGTCCCAGGAGCGGATCAA-3 0 (sense) and 5 0-GTT TGC AAC
TGC TGC GTT AG-3 0 (antisense) with an annealing temperature of
55 C; for Sox-9 (386-bp product), 5 0-GCG CGT GCA GCA CAA
GAA GGA CCA CCC GGA TTA CAA GTA C-3 0 (sense) and 5 0-
CGA AGG TCT CGA TGT TGG AGA TGA CGT CGC TGC TCA
GCT C-3 0 (antisense) with an annealing temperature of 62 C; for glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH; 299-bp product), 5 0-
TCACCATCTTCCAGGAGCGA-30 (sense) and 5 0-CACAATGCC
GAA GTG GTC GT-3 0 (antisense) with an annealing temperature of
50 C. To detect chick Wnt-3a (485-bp product), the primers were 5 0-
GTT CTG CAG CGA AGT GG TG-3 0 (sense) and 5 0-GAG TGT
CACAGCCGCAGATG-3 0 (antisense) and the annealing temperature
was 51 C. The primers for chickWnt-3a, rabbit c-Jun, and rabbit Sox-9
were designed based on the sequence of human homologs, and sequenc-
ing of PCR product showed 82%, 92%, and 93% homology with corre-
sponding human genes.2.5. Transfection and luciferase assay
Plasmids (2 lg) bearing dominant negative Tcf-4, which is a deletion
mutant lacking theN-terminal 30 amino acids [22], were transfected into
articular chondrocytes (day 2 cultures) using Lipofectamine (Gibco-
BRL) as described previously [16]. The transfected cells were cultured
for 36 h prior to treatment with other reagents. To determine b-cate-
nin-Tcf/Lef transcriptional activity, cells were transiently transfected
with 1 lgTcf/Lef reporter gene, TOPFLASH (optimal Lef-binding site),
or FOPFLASH (mutatedLef-binding site) (UpstateBiotechnology Inc.,
Lake Placid, NY), and 1 lg of pCMV-b-galactosidase. Luciferaseactivity was measured and normalized for transfection eﬃciency using
b-galactosidase activity [15,16]. Dominant negative Tcf-4 was transfec-
ted into chondrifying mesenchymal cells (2 · 107) by electroporation
(300 V, low X resistance, 330 lF capacity), and the cells were plated on
culture dishes and maintained as a micromass culture.
2.6. AP-1 activity assay
The DNA binding activity of AP-1 was determined using an AP-1
ELISA kit (Active Motif North America, Carlsbad, CA) as described
previously [17]. Brieﬂy, nuclei of chondrocytes were isolated with the
supplied lysis buﬀer. Nuclear protein (10 lg) was added to the wells
of an ELISA plate precoated with an oligonucleotide containing the
sequence 5 0-TGAGTCAG-3 0 and incubated for 1 h at room tempera-
ture. Mutated c-Jun oligonucleotide supplied in the kit was used as a
speciﬁcity control. AP-1 binding to the nucleotide was detected using
anti-phospho-c-Jun antibody and horseradish peroxidase-conjugated
secondary antibody with subsequent colorimetric detection.
2.7. Western blot analysis
Chondrocytes were lysed on ice for 30 min with buﬀer containing
50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, and
0.1% SDS supplemented with protease and phosphatase inhibitors as
described previously [16]. Proteins were fractionated by SDS–poly-
acrylamide gel electrophoresis and transferred to a nitrocellulose mem-
brane. The following antibodies were employed to detect proteins:
mouse anti-type II collagen monoclonal antibody (Chemicon, Teme-
cula, CA), mouse monoclonal antibodies against b-catenin or ERK-
1/2 (BD Transduction Laboratories), mouse monoclonal antibodies
against pc-Jun and pJNK, and rabbit polyclonal antibodies against
c-Jun and Sox-9 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).3. Results
3.1. Wnt-3a inhibits chondrogenesis by stabilizing cell–cell
adhesion
We ﬁrst examined expression of Wnt-3a in chondrifying
mesenchymal cells. RT-PCR showed that expression of Wnt-
3a was reduced during chondrogenesis (Fig. 1A). Addition of
exogenous Wnt-3a, in the form of conditioned medium from
L929 cells transfected with Wnt-3a cDNA, blocked type II col-
lagen expression (Fig. 1B) and suppressed the accumulation of
sulfated proteoglycans (Fig. 1C). Wnt-3a did not aﬀect the pat-
tern of staining by PNA, a speciﬁc marker for precartilage con-
densation [21], but it did inhibit cartilage nodule formation, as
demonstrated by Alcian blue staining (Fig. 1D). These results
indicate that downregulation of Wnt-3a is necessary for chon-
drogenesis and that exogenous Wnt-3a inhibits chondrogenesis
by blocking progression from precartilage condensation to car-
tilage nodule formation.
We further investigated the mechanisms by which Wnt-3a
regulates chondrogenesis, focusing on the role of b-catenin.
Staining for b-catenin was negative in cartilage nodules during
chondrogenesis (Fig. 2A), which is consistent with our previ-
ous observations [15]. Wnt-3a treatment caused a sustained
expression of b-catenin and blocked cartilage nodule forma-
tion (Fig. 2A). Expressed b-catenin protein in the presence of
Wnt-3a was localized mainly at the region of cell–cell contact
(Fig. 2A). Treatment of Wnt-3a moderately increased the tran-
scriptional activity of b-catenin, and this increase was com-
pletely blocked by ectopic expression of dominant negative
Tcf-4 (Fig. 2B). However, inhibition of type II collagen expres-
sion by Wnt-3a was not aﬀected by ectopic expression of dom-
inant negative Tcf-4 (Fig. 2C), suggesting that transcriptional
activity of the b-catenin-Tcf/Lef complex is not involved in
Wnt-3a regulation of chondrogenesis. Western blot analyses
Fig. 1. Wnt-3a inhibits chondrogenesis of mesenchymal cells. (A) Mesenchymal cells were maintained as a micromass culture for the indicated
periods, and expression of Wnt-3a was determined by RT-PCR. GAPDH was used as a loading control. (B) Mesenchymal cells were cultured for the
indicated periods in the absence or presence of 100 ll of Wnt-3a conditioned medium. Expression of type II collagen was determined by Western
blotting using ERK-1 as a loading control. (C) Mesenchymal cells were cultured for 4 days in the presence of indicated amount of Wnt-3a
conditioned medium, and accumulation of sulfated proteoglycan was determined by Alcian blue staining. (D) Chondrifying mesenchymal cells were
treated with 100 ll of control or Wnt-3a conditioned medium and stained with PNA (1.5-day culture) or Alcian blue (4-day culture). Data represent
the means ± S.D. (C) or a typical experiment selected from at least four independent experiments (A, B, D).
Fig. 2. Wnt-3a inhibits chondrogenesis independently of b-catenin transcriptional activity. (A) Chondrifying mesenchymal cells were treated for 4
days with 100 ll of control or Wnt-3a conditioned medium. Distribution of b-catenin was determined by immunohistochemical analysis of sections
from micromass culture spots (upper panel). The lower panel displays a higher magniﬁcation of the b-catenin staining pattern in cells treated with
Wnt-3a. (B, C) Mesenchymal cells were transfected with control () or myc-tagged dominant negative Tcf-4 (+) and then treated with 100 ll of
control or Wnt-3a conditioned medium for 36 h. b-Catenin transcriptional activity was determined using active (TOPFLASH) or inactive
(FOPFLASH) reporter genes (B). Expression of type II collagen and Tcf-4 was determined by Western blotting (C). (D) Mesenchymal cells were
treated with 100 ll of control or Wnt-conditioned medium for 1 or 5 days, and levels of b-catenin, N-cadherin, a-catenin, and ERK-1 were
determined by Western blotting. The results shown in (A), (C) and (D) are representative of typical experiments, whereas the values in (B) represent
the mean ± S.D. (n = 4).
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decrease in protein levels involved in cell–cell adhesion includ-
ing N-cadherin, a-catenin, and b-catenin and that exogenously
added Wnt-3a elevated their expression (Fig. 2D). Because
progression from precartilage condensation to cartilage
nodules requires loss of cell–cell contact, these results support
the idea that Wnt-3a inhibits chondrogenesis by stabilizing
cell–cell adhesion, thereby blocking cartilage nodule forma-
tion, rather than by modulating the transcriptional activity
of b-catenin.
3.2. Wnt-3a triggers dediﬀerentiation of primary cultured
articular chondrocytes
We next investigated the eﬀects of Wnt-3a on the mainte-
nance of the diﬀerentiated phenotype of primary cultured
articular chondrocytes. As shown in Fig. 3A, Wnt-3a sup-
pressed type II collagen expression and the onset of type I col-
lagen expression, which is a hallmark of chondrocyte
dediﬀerentiation. We therefore investigated the mechanism
by which Wnt-3a causes dediﬀerentiation, speciﬁcally focusing
on the role of b-catenin in type II collagen expression. Similarto the pattern during chondrogenesis, Wnt-3a increased levels
of N-cadherin, a-catenin, and b-catenin in primary cultured
chondrocytes (Fig. 3A). However, unlike the pattern in chon-
drogenesis, Wnt-3a caused a signiﬁcant translocation of b-
catenin to the nucleus (Fig. 3B) and increased b-catenin-Tcf/
Lef complex transcriptional activity (Fig. 3C). Wnt-3a-induced
transcriptional activity of b-catenin (Fig. 3C) and inhibition of
type II collagen expression (Fig. 3D) were substantially re-
duced by ectopic expression of dominant negative Tcf-4. Addi-
tionally, consistent with the inhibition of type II collagen
expression, Wnt-3a caused suppression of Sox-9 expression
(Fig. 3D and E), a major transcription factor that regulates
type II collagen (COL2A1) expression [1]. Taken together,
the above results suggest that Wnt-3a inhibits type II collagen
expression by activating b-catenin-Tcf/Lef transcriptional
activity and subsequent suppression of Sox-9.
3.3. c-Jun/AP-1 mediates Wnt-3a-induced dediﬀerentiation of
chondrocytes
Our previous studies indicated that c-Jun/AP-1 mediates
IL-1b-induced dediﬀerentiation of chondrocytes [17] and that
Fig. 3. Wnt-3a causes dediﬀerentiation of chondrocytes via b-catenin-Tcf/Lef signaling. (A) Primary cultured articular chondrocytes were treated
with the indicated volumes of Wnt-3a conditioned medium for 48 h. The expression of types I and II collagen were determined by RT-PCR (upper
panel) and the levels of type I collagen, N-cadherin, a-catenin, and b-catenin were determined by Western blotting (lower panel). GAPDH and ERK
were used as loading controls. (B) Chondrocytes were treated with 100 ll of control or Wnt-3a conditioned medium for 48 h, after which distribution
of b-catenin was determined by immunoﬂuorescence microscopy. (C, D) Chondrocytes were transfected with control () or myc-tagged dominant
negative Tcf-4 (+) and then treated with 100 ll of control or Wnt-3a conditioned medium for 48 h. Transcriptional activity (C) and expression of type
II collagen, Tcf-4, and Sox-9 (D) were determined by Western blotting. (E) Chondrocytes were treated with the indicated volumes of Wnt-3a
conditioned medium for 48 h. The expression of Sox-9 was determined by RT-PCR and Western blotting. GAPDH and ERK were used as loading
controls.
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fore examined whether c-Jun/AP-1 mediates Wnt-3a-induced
dediﬀerentiation of chondrocytes. As observed in IL-1b-trea-
ted chondrocytes [17], Wnt-3a treatment enhanced the expres-
sion of c-Jun mRNA and protein and stimulated the
phosphorylation of c-Jun and c-Jun N-terminal kinase
(JNK) (Fig. 4A). c-Jun phosphorylation is dependent on the
activation of JNK because SP600125, a speciﬁc inhibitor of
JNK [23], blocked c-Jun phosphorylation (Fig. 5C). The phos-
phorylated c-Jun is localized in nuclei of chondrocytes
(Fig. 4B), which is consistent with its function as a component
of transcription factors.
Consistent with the phosphorylation and nuclear localiza-
tion of c-Jun, Wnt-3a stimulated AP-1 activity (i.e., the
DNA binding activity of c-Jun) (Fig. 5A), which is similar to
the eﬀects of IL-1b [17]. As shown in Fig. 5B, Wnt-3a activa-
tion of AP-1 was blocked by the inhibition of JNK with
SP600125 and by the inhibition of AP-1 with N-acetyl-L-cys-
teine and nordihydroguaiaretic acid [24,25]. The inhibition ofFig. 4. Wnt-3a causes JNK activation and expression as well as ph
(A) Chondrocytes were treated with 100 ll of Wnt-3a conditioned medium
by RT-PCR and Western blotting. Phosphorylation of c-Jun (pc-Jun) and JN
were used as loading controls. (B) Chondrocytes were treated with 100 ll
localization of c-Jun were determined by immunoﬂuorescence microscopy. CAP-1 with these compounds also prevented the inhibition of
Sox-9 and type II collagen expression by Wnt-3 (Fig. 5C).
Combined with our previous observations that ectopic expres-
sion of c-Jun is suﬃcient to block the expression of Sox-9 and
type II collagen [17] and the known fact that c-Jun is a target
gene for b-catenin-Tcf/Lef transcriptional complex [30], our
results indicate that Wnt-3a causes dediﬀerentiation of
chondrocytes through stimulation of b-catenin-Tcf/Lef,
c-Jun expression, AP-1 activation, and suppression of Sox-9
expression.4. Discussion
Many of the cellular eﬀects regulated by Wnt signaling are
exerted by the modulation of b-catenin [26,27]. Wnt signaling
inhibits glycogen synthase kinase-3b, which facilitates cyto-
solic accumulation of b-catenin by inhibiting its proteolysis.
Accumulated b-catenin associates with members of the Tcf/osphorylation and nuclear localization of c-Jun in chondrocytes.
for the indicated time period. The expression of c-Jun was determined
K (pJNK) were determined by Western blotting. ERK and GAPDH
of control or Wnt-3a conditioned medium for 24 h. Expression and
ells were identiﬁed by staining with DAPI.
Fig. 5. c-Jun/AP-1 mediates Wnt-3a-regulated dediﬀerentiation of chondrocytes. (A) Chondrocytes were treated with 100 ll of Wnt-3a conditioned
medium for the indicated time period, after which AP-1 activity was determined. (B, C) Chondrocytes were pretreated with vehicle alone () or
20 lm SP600125 (SP), 15 lm N-acetyl-L-cysteine (NAC), or 15 lm nordihydroguaiaretic acid (NDGA) for 30 min and the exposed to 100 ll of Wnt-
3a conditioned medium for additional 24 h. AP-1 activity was determined by using an ELISA kit (B). Levels of c-Jun, phosphorylated c-Jun (pc-Jun),
phosphorylated JNK (pJNK), type II collagen, and Sox-9 were determined by Western blotting (C). ERK was used as a loading control.
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the transcription of target genes. In addition to its function
as a transcriptional co-activator, b-catenin participates in
cell–cell adhesion by interacting with cadherin [26,27]. We
demonstrated in this study that Wnt-3a inhibits chondrogene-
sis of mesenchymal cells and induces the dediﬀerentiation of
diﬀerentiated articular chondrocytes. We also showed that
the ability of Wnt-3a to inhibit chondrogenesis is independent
of b-catenin-Tcf/Lef transcriptional activity, whereas the
induction of dediﬀerentiation requires b-catenin transcrip-
tional activity and activation of the c-Jun AP-1 pathway.
The inhibitory eﬀects of Wnt-3a on chondrogenesis stand in
contrast to recent results obtained by Fischer et al. [9]. They
showed that bone morphogenetic protein-2 upregulates Wnt-
3a and that exogenous Wnt-3a enhances bone morphogenetic
protein-2-mediated chondrogenesis in murine C3H10T1/2 mes-
enchymal cells. Although this discrepancy may be due to diﬀer-
ences in the experimental systems, such as the origin of the cells
(murine cell line vs. chick limb bud mesenchymal cells) and
extracellular stimuli (bone morphogenetic protein-2 vs. serum),
the speciﬁc reasons are currently unclear. Our current results on
the inhibition of chondrogenesis by Wnt-3a are similar to
results from studies on Wnt-7a [4,7,28]. As with Wnt-7a
[7,28], Wnt-3a inhibited micromass culture-induced chondro-
genesis of chick limb bud mesenchymal cells by stabilizing
cell–cell adhesion. Consistent with this, inhibition of b-catenin
transcriptional activity by ectopic expression of dominant neg-
ative Tcf-4 did not aﬀect the inhibition of chondrogenesis by
Wnt-3a. Our current results further show that the Wnt-3a inhi-
bition of chondrogenesis occurred along with sustained expres-
sion of N-cadherin, a-catenin and b-catenin. Given thatWnt-3a
does not inhibit precartilage condensation but blocks cartilage
nodule formation and that stabilization of cell–cell adhesion
mediated by N-cadherin inhibits chondrogenesis by blocking
cartilage nodule formation [7,15,28], we speculate that Wnt-3a
inhibits chondrogenesis at the step of cartilage nodule forma-
tion by promoting sustained expression of N-cadherin and its
associated cytoskeletal components (i.e., a- and b-catenin).
In contrast to the inhibition of chondrogenesis, Wnt-3a-in-
duced dediﬀerentiation of articular chondrocytes is mediatedby the stimulation of b-catenin-Tcf/Lef transcriptional activity
and subsequent suppression of sox-9 expression. The role of b-
catenin in chondrocyte dediﬀerentiation was further supported
by the observation that ectopic expression of S37A b-catenin
inhibits expression of both type II collagen [15] and sox-9 (data
not shown). The results are consistent with our previous obser-
vation that activation of b-catenin transcriptional activity is
suﬃcient to cause dediﬀerentiation [15,16]. Thus, our results
indicate that the mechanisms underlying Wnt-induced dediﬀer-
entiation are distinct from those of diﬀerentiation and depend
on the transcriptional activity of b-catenin. This conclusion is
in agreement with the report by Bergwitz et al. [29] that several
Wnt proteins (including Wnt-1, -3a, -4, -7a and -7b) suppress
type II collagen reporter gene expression in NIH3T3 cells.
Therefore, our current and previous ﬁndings that Wnt-3 and
-7a cause dediﬀerentiation of chondrocytes and that IL-1b,
the primary pro-inﬂammatory cytokine involved in cartilage
destruction, induces expression of several Wnt proteins [16],
strongly suggest the involvement of Wnt signaling in cartilage
destruction as well as in the regulation of chondrogenesis and
cartilage development.
In addition to the requirement of b-catenin-Tcf/Lef signal-
ing, we demonstrated here that Wnt-3a requires c-Jun/AP-1
signaling for the induction of chondrocyte dediﬀerentiation.
The requirement for c-Jun is consistent with the fact that
c-Jun is a target gene for b-catenin-Tcf/Lef transcriptional
complex [30]. It has also been shown that Wnt and the friz-
zled receptor activate the JNK pathway [31]. Therefore, it is
likely that Wnt signaling causes induction of c-Jun expres-
sion and the activation of JNK to phosphorylate c-Jun,
which leads to the activation of the AP-1 transcription fac-
tor. Based on our previous observations that activation of
AP-1 is suﬃcient to inhibit Sox-9 expression and the subse-
quent blockade of type II collagen expression [17], our re-
sults indicate that Wnt-3a induces dediﬀerentiation of
chondrocytes by stimulating b-catenin-Tcf/Lef transcriptional
activity and activating the c-Jun/AP-1 pathway. Additionally,
the observations that IL-1b promotes the expression of sev-
eral Wnt proteins in articular chondrocytes [16] and that
Wnt protein itself is suﬃcient to cause their dediﬀerentiation
4842 S.-G. Hwang et al. / FEBS Letters 579 (2005) 4837–4842suggest the involvement of Wnt expression in IL-1b-induced
chondrocyte dediﬀerentiation.
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